Literature DB >> 19718647

The natural history of hepatitis C cirrhosis after liver transplantation.

Roberto J Firpi1, Virginia Clark, Consuelo Soldevila-Pico, Giuseppe Morelli, Roniel Cabrera, Cynthia Levy, Victor I Machicao, Chen Chaoru, David R Nelson.   

Abstract

Hepatitis C after liver transplantation leads to graft cirrhosis in up to 30% of patients within 5 years, but limited data exist regarding the clinical course of cirrhosis after transplantation. The aims of this study were to report the natural history of hepatitis C cirrhosis after liver transplantation and to identify risk factors for decompensation and survival. Hepatitis C patients underwent protocol liver biopsies yearly after liver transplantation. After cirrhosis was identified by biopsy, the outcomes of interest were the development of decompensation, death, or retransplantation for hepatitis C. Kaplan-Meier and Cox regression analysis was used to determine survival and risk factors for decompensation and mortality. Out of 502 liver transplants performed for hepatitis C, 88 patients (18%) had cirrhosis within 3.7 years. Seventy-one patients were compensated at diagnosis. The cumulative probability of decompensation 1 year after cirrhosis was 30%. A Model for End-Stage Liver disease score >or= 16 was predictive of decompensation and poor survival, whereas successful interferon treatment was found to reduce this risk (relative risk = 0.05). Once decompensation occurred, 1-year survival was 46%. In conclusion, the results confirm an accelerated natural history of hepatitis C cirrhosis after liver transplantation and demonstrate poor survival after decompensation. The Model for End-Stage Liver Disease can stratify risk for decompensation and survival, whereas successful antiviral therapy may be protective. (c) 2009 AASLD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19718647     DOI: 10.1002/lt.21784

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  28 in total

1.  Liver transplantation in acute alcoholic hepatitis: Current status and future development.

Authors:  Ashwani K Singal; Andrea Duchini
Journal:  World J Hepatol       Date:  2011-08-27

Review 2.  Recurrent hepatitis C after liver transplant.

Authors:  Andrew S deLemos; Paul A Schmeltzer; Mark W Russo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  Impact of new treatment options for hepatitis C virus infection in liver transplantation.

Authors:  Elda Righi; Angela Londero; Alessia Carnelutti; Umberto Baccarani; Matteo Bassetti
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 4.  Surgical approach for hepatitis C virus-related hepatocellular carcinoma.

Authors:  Junichi Shindoh; Masaji Hashimoto; Goro Watanabe
Journal:  World J Hepatol       Date:  2015-01-27

5.  Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation.

Authors:  Francesca Romana Ponziani; Eleonora Brigida Annicchiarico; Massimo Siciliano; Francesca D'Aversa; Maurizio Pompili; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

Review 6.  Management of recurrent hepatitis C virus after liver transplantation.

Authors:  Miguel Jiménez-Pérez; Rocío González-Grande; Francisco Javier Rando-Muñoz
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

7.  Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis.

Authors:  Hiroshi Sogawa; Brian Shrager; Ghalib Jibara; Parissa Tabrizian; Sasan Roayaie; Myron Schwartz
Journal:  HPB (Oxford)       Date:  2012-08-30       Impact factor: 3.647

Review 8.  Management of hepatitis C infection before and after liver transplantation.

Authors:  Stefano Fagiuoli; Roberto Ravasio; Maria Grazia Lucà; Anna Baldan; Silvia Pecere; Alessandro Vitale; Luisa Pasulo
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

9.  Antiviral treatment for hepatitis C virus infection after liver transplantation.

Authors:  Yasuhiko Sugawara; Sumihito Tamura; Norihiro Kokudo
Journal:  Hepat Res Treat       Date:  2010-11-01

10.  Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.

Authors:  Alice Tung Wan Song; Rodolphe Sobesky; Carmen Vinaixa; Jérôme Dumortier; Sylvie Radenne; François Durand; Yvon Calmus; Géraldine Rousseau; Marianne Latournerie; Cyrille Feray; Valérie Delvart; Bruno Roche; Stéphanie Haim-Boukobza; Anne-Marie Roque-Afonso; Denis Castaing; Edson Abdala; Luiz Augusto Carneiro D'Albuquerque; Jean-Charles Duclos-Vallée; Marina Berenguer; Didier Samuel
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.